First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis
Maria Pouyiourou(Heidelberg University), A. Meyer(Humboldt-Universität zu Berlin), Andrea Stroux(Humboldt-Universität zu Berlin), Andreas Viardot(University Hospital Ulm), Paul La Rosée(Jena University Hospital), Georg Maschmeyer(Klinikum Ernst von Bergmann), D. Kämpfe(Klinikum Lüdenscheid), Christoph Kahl(Klinikum Magdeburg), Vladan Vučinić(University Hospital Leipzig), Astrid Monecke(University Hospital Leipzig), Carsten Hirt(Universitätsmedizin Greifswald), Thomas Weber(University Hospital in Halle), Julia Meißner(Heidelberg University), Mathias Witzens‐Harig(Heidelberg University), Sebastian Böttcher(Universitätsmedizin Rostock), Harald Schmalenberg(Städtisches Klinikum Dresden), Reinhard Marks(University Medical Center Freiburg), Gabriele Prange‐Krex, Frank Kroschinsky(University Hospital Carl Gustav Carus), Elke Hauf(TUM Klinikum), Ulrich Keller(TUM Klinikum), Karoline Koch(University Hospital Schleswig-Holstein), Wolfgang Hiddemann(University Hospital Schleswig-Holstein), Michael Herold(Helios Klinikum Erfurt), Christian W. Scholz(Vivantes Klinikum), on behalf of the East German Study Group for Hematology and Oncology (OSHO)
Cited by 19
Abstract
Related Papers
No related papers found
Powered by citation graph analysis